Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $984.59 Million |
|---|---|
| Enterprise Value | $-48,689,406,000.00 |
| Annual dividend | $1.25 |
| Dividend yield | 4.97% |
| Earnings per Share | $57.52 |
| Beta | 0.13 |
| Outstanding Shares | 37,869,000 |
| P/E Ratio | 15.83 |
|---|---|
| PEG | -9.89 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 1.1 |
| Enterprise Value to EBIT | 10.32 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.03 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Kaken Pharmaceutical Co., Ltd. is involved in the development, manufacturing, and commercialization of a diverse range of medical goods, health devices, and agricultural chemicals, serving both domestic and global markets. Their extensiv...